APPLICATION SITE LACERATION

This adverse event was reported 414 times

APPLICATION SITE LACERATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BABY PETROLEUM JELLY 1 0.0097
1 WHITE PETROLATUM JELLY 1 0.0096
2 HALOBETASOL PROPIONATE AND TAZAROTENE 1 0.0051
3 MENTHOL, METHYL SALICYLATE 2 0.0033
4 PHENAZOPYRIDINE HYDROCHLORIDE 1 0.0030
5 MECHLORETHAMINE HYDROCHLORIDE 4 0.0018
6 AMINOLEVULINIC ACID HYDROCHLORIDE 3 0.0017
7 NORELGESTROMIN AND ETHINYL ESTRADIOL 2 0.0011
8 PEGFILGRASTIM 10 0.0008
9 NATEGLINIDE 1 0.0007
See all drugs enriched for association with APPLICATION SITE LACERATION

APPLICATION SITE LACERATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Aryl Hydrocarbon Receptor Agonist [EPC] 1 0.0005
1 Estrogen Agonist/Antagonist [EPC] 1 0.0004
2 Human Immunoglobulin G [EPC] 8 0.0004
3 Provitamin D2 Compound [EPC] 11 0.0004
4 Amide Local Anesthetic [EPC] 30 0.0003
5 Monoamine Oxidase Inhibitor [EPC] 1 0.0003
6 Antiarrhythmic [EPC] 30 0.0003
7 Cholinergic Nicotinic Agonist [EPC] 17 0.0003
8 Estrogen [EPC] 42 0.0002
9 Partial Opioid Agonist [EPC] 18 0.0002
See all drug classes enriched for association with APPLICATION SITE LACERATION